PARIS--(BUSINESS WIRE)--A new international clinical trial provides further evidence on the efficacy of combining chondroitin sulfate and glucosamine for the symptomatic treatment of knee osteoarthritis (OA). The results show that this drug combination significantly improves, to a clinically relevant degree, patient’s pain, functional capacity, stiffness, inflammation, joint effusion, and overall quality of life. “It further confirms the powerful effect of combining chondroitin sulfate and glucosamine for the treatment of osteoarthritis .Its efficacy is comparable to that of an anti-inflammatory drug but with a much better safety profile”, declares Professor Jean Pierre Pelletier, rheumatologist at the University of Montreal and member of the scientific committee of the study.
Help employers find you! Check out all the jobs and post your resume.
